Amanote Research

Amanote Research

    RegisterSign In

Timing of Supplementation of Selenium and Isoflavones Determines Prostate Cancer Risk Factor Reduction in Rats

Nutrition and Metabolism - United Kingdom
doi 10.1186/1743-7075-5-31
Full Text
Open PDF
Abstract

Available in full text

Categories
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
Date

January 1, 2008

Authors
Jessica R TolmanEdwin D. LephartKenneth DR SetchellDennis L EggettMerrill J Christensen
Publisher

Springer Science and Business Media LLC


Related search

Selenium- Or Vitamin E-Related Gene Variants, Interaction With Supplementation, and Risk of High-Grade Prostate Cancer in SELECT

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2016English

Status of Selenium in Prostate Cancer Prevention

British Journal of Cancer
Cancer ResearchOncology
2004English

Chemoprevention Trial of Selenium and Prostate Cancer

1999English

Chemoprevention Trial of Selenium and Prostate Cancer

2001English

Biomarkers of Selenium Action in Prostate Cancer

2005English

Dietary Isoflavones and Breast Cancer Risk

Medicines
2017English

Genetics Risk Factor for Prostate Cancer

2004English

Selenium and Risk of Bladder Cancer

Hereditary Cancer in Clinical Practice
OncologyGenetics
2012English

Incidence of Prostate Cancer in Male Breast Cancer Patients: A Risk Factor for Prostate Cancer Screening

Prostate Cancer and Prostatic Diseases
Cancer ResearchOncologyUrology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy